FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Remifentanil (Ultiva) Lyophilized Powder for Solution Injection
Status: Currently in Shortage
»Date first posted: 02/06/2018
»Therapeutic Categories: Analgesia/Addiction; Pediatric

Expand all

Fresenius Kabi USA, LLC (Reverified 05/03/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg per vial, SDV (NDC 63323-723-03) Backordered. Next release due July 2018. Demand increase for the drug
2 mg per vial, SDV (NDC 63323-724-05) Backordered. Next release due July 2018. Demand increase for the drug
5 mg per vial, SDV (NDC 63323-725-10) Backordered. Next release due July 2018. Demand increase for the drug

Mylan Institutional (Reverified 05/22/2018)

Company Contact Information:
800-RXMYLAN (1-800-796- 9526)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg (NDC 67457-198-03) Intermittent supply until Q3 2018 Other
2 mg (NDC 67457-198-05) Intermittent supply until Q3 2018 Other
5 mg (NDC 67457-198-10) Intermittent supply until Q3 2018 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English